Market Overview

Top 10 Pre-Market Gainers From Thursday

  • Repros Therapeutics (NASDAQ: RPRX) was trading up 19.53% after reporting success of its Enclomiphene drug to treat secondary hypogonadism. The Drug is on track for registration decision in Fall 2017.
  • Achaogen Inc. (NASDAQ: AKAO) up 9.55% after awarded $20 million contract option by BARDA to support development of Plazomicin for Multi-Drug Resistant Gram-Negative Infections.
  • Ciena Corporation... (NASDAQ: CIEN) rose 9.18% after beating earnings estimates this morning.
  • Broadwind Energy (NASDAQ: BWEN) jumped 21.43% after signing $137 million wind turbine tower supply agreement.
  • Joy Global Inc. (NYSE: JOY) traded up 9.65% after beating EPS estimates.
  • Donaldson Company... (NYSE: DCI) was trading up 7.42% after beating earnings estimates this morning.
  • Concordia Healthcare (NASDAQ: CXRX) up 7.25% after the company reported it has completed acquisition of four generic products.
  • Dermira Inc. (NASDAQ: DERM) jumped 5.47% after reporting positive topline results from two pivotal phase 3 clinical trials for DRM04 in patients with primary Axillary Hyperhidrosis.
  • Keryx Biopharm (NASDAQ: KERX) traded up 6.52% after showing Baupost's 42.53% stake as of May 27.
  • Pure Storage Inc (NYSE: PSTG) was trading up 4.86% after UBS upgraded the company to Buy.

Posted-In: Pre-Market Outlook Movers


Related Articles (BWEN + AKAO)

View Comments and Join the Discussion!

Achaogen's Patient Enrollment In Final Stage EPIC Registration Trial Of Plazomicin Reaches 50%

Exxon Mobil Shares Indicated Lower Following BofA Downgrade